Advanced search
Publication Cover
Oncology Issues Volume 36, 2021 - Issue 2
Journal homepage
53
Views
1
CrossRef citations to date
0
Altmetric
Articles

Improving The Quality of Care for Persons With Advanced Epithelial Ovarian Cancer

Premal H. ThakerView further author information
, MD, MS,
Matthew P. SmeltzerView further author information
, PhD,
Monique DawkinsView further author information
, EdD,
Leigha Senter-JamiesonView further author information
, MS,
Stephanie V. BlankView further author information
, MD,
Destin BlackView further author information
, MD,
Mollie FinkelView further author information
, RN, MSN,
Anna YemelyanovaView further author information
, MD,
Leigh M. BoehmerView further author information
, PharmD, BCOP &
Sarah TemkinView further author information
, MD show all
Pages 36-48 | Published online: 24 Mar 2021

References

  • SiegelRL, MillerKD, JemalA. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7-30.
  • TorreLA, TrabertB, DeSantisCE, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284-296.
  • American Cancer Society. Cancer Facts & Figures 2020. Atlanta, GA: American Cancer Society; 2020.
  • CollinsY, HolcombK, Chapman-DavisE, KhabeleD, FarleyJH. Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol. 2014;133(2):353-361.
  • BristowRE, PowellMA, Al-HammadiN, et al. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst. 2013;105(11):823-832.
  • TemkinSM, RimelBJ, BrueglAS, GundersonCC, BeavisAL, DollKM. A contemporary framework of health equity applied to gynecologic cancer care: a Society of Gynecologic Oncology evidenced-based review. Gynecol Oncol. 2018;149(1):70-77.
  • BristowRE, ChangJ, ZiogasA, CamposB, ChavezLR, Anton-CulverH. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines. Obstet Gynecol. 2015;125:833-842.
  • MooreK, ColomboN, ScambiaG, et al. Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med. 2018;379:2495-2505.
  • BanerjeeS, MooreKN, ColomboN, et al. Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year follow-up (f/u) from SOLO1. Ann Oncol. 2020;31(suppl 4):S613.
  • ArmstrongDK, AlvarezRD, Bakkum-GamezJN, et al. NCCN Guidelines insights: ovarian cancer, version 1.2019. J Natl Compr Canc Netw. 2019;17(8):896-909.
  • ChenF, BaileyCE, AlvarezRD, ShuXO, ZhengW. Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer. Gynecol Oncol. 2021;160(1):10-15.
  • QualtrixXM. Available online at: https://www.qualtrics.com. Last accessed December 18, 2020.
  • CleghornGD, HeadrickLA. The PDSA cycle at the core of learning in health professions education. Jt Comm J Qual Improv. 1996;22(3):206-212.
  • Key Driver 2: Implement a Data-Driven Quality Improvement Process to Integrate Evidence into Practice Procedures. Rockville, MD: Agency for Healthcare Research and Quality. Available online at: https://www.ahrq.gov/evidencenow/tools/keydrivers/implement-qi.html.
  • BiteSizeQI. Available online at: https://bitesizeqi.org. Last accessed December 18, 2020.
  • González-MartínA, PothuriB, VergoteI, et al., and the PRIMA/ENGOT-OV26/GOG-3012 Investigators. Niraparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med. 2019;381(25):2391-2402.
  • Ray-CoquardI, PautierP, PignataS, et al., and the PAOLA-1 Investigators. Olaparib plus bevacizumab as first-line maintenance in ovarian cancer. N Engl J Med. 2019;381(25):2416-2428.
  • BristowRE, ChangJ, ZiogasA, Anton-CulverH. Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol. 2013;121(6):1226-1234.
  • VillanuevaC, ChangJ, ZiogasA, BristowRE, VieiraVM. Ovarian cancer in California: guideline adherence, survival, and the impact of geographic location, 1996-2014. Cancer Epidemiol. 2020;69:101825.
  • VillanuevaC, ChangJ, BartellSM, ZiogasA, BristowR, VieiraVM. Contribution of geographic location to disparities in ovarian cancer treatment. J Natl Compr Canc Netw. 2019;17(11):1318-132.
  • TemkinSM, RubinsakL, BenoitMF, et al. Take me to your leader: reporting structures and equity in academic gynecologic oncology. Gynecol Oncol. 2020;157(3):759-764.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.